Compass Therapeutics

Leadership Changes

Bloomios Appoints Industry Veteran, Joe Reid, as Chief Manufacturing Officer

SANTA BARBARA, Calif., March 27, 2023 /PRNewswire/ -- Bloomios, Inc. (the "Company") (OTCQB: BLMS), a leading white-label and private-label manufacturer and wholesaler of hemp-derived nutraceutical, cosmetics and pet products, has appointed Upexi's former production division operations head, Joe Reid, as chief manufacturing officer of Bloomios' wholly owned subsidiary, Bloomios Private Label. Reid brings to Bloomios more than a...Read more


Aadi Bioscience Appoints Mohammad Hirmand, M.D. to Board of Directors

March 27
Last Trade: 7.12 -0.13 -1.79

LOS ANGELES, March 27, 2023 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, today announced the appointment of Mohammad Hirmand, M.D. to its Board of Directors.  Dr. Hirmand has more than 20 years of biotechnology clinical development experience, and...Read more


Coya Therapeutics Strengthens Leadership Team with Addition of Arun Swaminathan, Ph.D. as Chief Business Officer

March 27
Last Trade: 4.10 0.04 0.99

Dr. Swaminathan will be responsible for establishing and leading business development, leveraging his expertise in licensing, transactions, and establishing strategic collaborations within the biotechnology and pharmaceutical industries. In his two prior companies serving as Chief Business Officer, Dr. Swaminathan demonstrated strong deal making ability - At Alteogen, he executed $3.8 billion and $1.4 billion deals with two top ten...Read more


Terns Pharmaceuticals Appoints Emil Kuriakose, M.D., as Chief Medical Officer of Terns Oncology

March 27
Last Trade: 9.30 0.38 4.26

FOSTER CITY, Calif., March 27, 2023 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology, non-alcoholic steatohepatitis (NASH) and obesity, today announced the appointment of Emil Kuriakose, M.D. as chief medical officer of Terns oncology, effective May...Read more


BioSig Technologies Announces New Advisory Board Member Edwin Wang

March 27
Last Trade: 1.11 -0.01 -0.89

Westport, CT, March 27, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering unprecedented accuracy and precision to intracardiac signal visualization with its proprietary PURE EP™ System, today announced the appointment of new Advisory Board member Edwin Wang. Mr. Wang has over 20 years of impactful experience in private...Read more


Stuart Peltz, Ph.D., Rare Disease Pioneer, to Retire as Chief Executive Officer of PTC Therapeutics

March 24
Last Trade: 44.68 0.50 1.13

Chief Operating Officer Matthew Klein, M.D., M.S., F.A.C.S. to become Chief Executive Officer and join the Board of Directors  Conference call to be held today, Fri., March 24th at 8:30 am ET SOUTH PLAINFIELD, N.J., March 24, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT). Stuart Peltz, Ph.D., founding Chief Executive Officer (CEO) of PTC Therapeutics announced today that he is stepping down after 25 years. Dr....Read more


BioSig Technologies Announces New Advisory Board Member Lorraine Spurge

March 24
Last Trade: 1.11 -0.01 -0.89

Westport, CT, March 24, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering unprecedented accuracy and precision to intracardiac signal visualization with its proprietary PURE EP™ System, today announced the appointment of Lorraine Spurge, entrepreneur and financier, to its Advisory Board. As founder and CEO of Maple Stone...Read more


Celyad Oncology appoints Georges Rawadi as its new CEO

March 24
Last Trade: 0.88

MONT-SAINT-GUIBERT, Belgium, March 24, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext & Nasdaq: CYAD) (the “Company”), a biotechnology company focused on innovative technologies for chimeric antigen receptor (CAR) T-cell therapies, is pleased to announce Georges Rawadi as its new Chief Executive Officer (CEO), effective as of March 23, 2023, with starting date April 17, 2023. Michel Lussier will continue to serve as Interim CEO...Read more


Monte Rosa Therapeutics Appoints Dr. Jan Skvarka to Board of Directors

March 23
Last Trade: 7.01 0.26 3.86

BOSTON, March 23, 2023 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE), a clinical stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced the appointment of Jan Skvarka, Ph.D., MBA to its Board of Directors. Dr. Skvarka is an accomplished biopharmaceutical executive bringing over three decades of extensive operational, strategic and financial expertise to the...Read more


MIMEDX Announces Chief Financial Officer Transition

March 23
Last Trade: 3.42 0.03 0.74

MARIETTA, Ga., March 23, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a pioneer and leader in placental biologics, today announced that Peter M. Carlson, Chief Financial Officer, has decided to leave the Company to pursue other opportunities. The Company has initiated a search for its next Chief Financial Officer and Mr. Carlson will be assisting MIMEDX throughout this process to ensure a smooth...Read more


Leading Cancer Patient Advocate Kelly Shanahan, M.D., Joins Jaguar Health's Scientific Advisory Board

March 23
Last Trade: 1.01 -0.12 -10.62

SAN FRANCISCO, CA / ACCESSWIRE / March 23, 2023 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") and its wholly owned subsidiary Napo Pharmaceuticals (Napo) today announced that Dr. Kelly Shanahan, a former clinician and a metastatic breast cancer patient who is now a full-time independent patient advocate, has joined the Jaguar/Napo Scientific Advisory Board (SAB). "We are very pleased that Dr. Shanahan has joined our...Read more


Beyond Air® Appoints Jeff Myers, M.D. Ph.D. as Chief Medical Officer

March 23
Last Trade: 6.25 0.11 1.79

GARDEN CITY, N.Y., March 23, 2023 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hypertension, and, through its affiliate Beyond Cancer, Ltd., ultra-high concentration nitric oxide...Read more


JanOne Welcomes John Bonfiglio -- Veteran Biotech Executive, Deal Maker and Strategist -- to Top Management Team

March 23
Last Trade: 1.18 -0.16 -11.95

Bonfiglio is known for raising capital, building start-ups, and leading successful biotech companies as CEO and COO.      LAS VEGAS, March 23, 2023 /PRNewswire/ -- JanOne (Nasdaq: JAN), a biopharmaceutical company specializing in developing non-addicting pain killers and treatments for underlying causes of pain, announced the hiring of John N. Bonfiglio, PhD, as interim president of its JanOne Biotech subsidiary....Read more


Gerry O’Sullivan, the Latest Member to Join Microbot Medical’s Scientific Advisory Board, to Leverage Extensive Interventional Radiology Experience to Progress the LIBERTY® Robotic System Through Regulatory, Clinical and Commercialization Phases

Widely Published Interventional Radiologist Has Earned Well-Regarded Reputation Working with Prestigious Medical Centers in the U.S. and Europe The addition of Professor O’Sullivan, the Clinical Director of Radiology for the Galway Clinic in Ireland, Expands the Company’s EU Presence. HINGHAM, Mass., March 23, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) continues to receive global interest from interventional...Read more


Jasper Therapeutics Appoints Daniel Adelman, M.D., as Acting Chief Medical Officer

March 23
Last Trade: 1.96 -0.05 -2.25

REDWOOD CITY, Calif., March 23, 2023 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address diseases such as chronic spontaneous urticaria, lower to intermediate risk myelodysplastic syndromes (MDS) as well as novel stem cell transplant conditioning regimes, today announced the appointment of Daniel...Read more


ReShape Lifesciences Announces Formation of International Scientific Advisory Board

March 23
Last Trade: 2.81 -0.27 -8.77

SAN CLEMENTE, Calif., March 23, 2023 (GLOBE NEWSWIRE) --  ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced the formation of a Scientific Advisory Board (SAB). Members include internationally recognized experts and surgeons in the obesity and metabolic disease fields. The newly created SAB will provide management with strategic input and external...Read more


Phreesia Announces Chief Financial Officer Transition

March 22
Last Trade: 31.80 0.30 0.95

WILMINGTON, Del. / Mar 22, 2023 / Business Wire / Phreesia, Inc. (NYSE: PHR), a leader in patient intake, outreach and activation, today announced the appointment of Balaji Gandhi as Phreesia’s Chief Financial Officer. Gandhi will succeed Randy Rasmussen, effective March 24, 2023. Rasmussen will serve as a Strategic Advisor to the Company for a period of time, to facilitate a smooth transition of his responsibilities. Gandhi has over 25...Read more


Inogen Announces Appointment of Tom West to Board of Directors and Retirement of Board Member Kristen Miranda

March 22
Last Trade: 12.45 0.04 0.32

GOLETA, Calif. / Mar 22, 2023 / Business Wire / Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Tom West to Inogen’s Board of Directors, effective April 1, 2023. The company also announced that Kristen Miranda, who has served as a director since March 2021, will retire as a member of the Board of Directors, effective March...Read more


Semler Scientific Names Wayne T. Pan, M.D., Ph.D., M.B.A. as New CEO Effective April 3, 2023

March 21
Last Trade: 25.81 0.08 0.31

SANTA CLARA, Calif., March 21, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, announces that Doug Murphy-Chutorian, M.D. has informed the board of directors of his intention to step down from his position as chief executive officer (CEO) of Semler Scientific and assist for a transition period. He will...Read more


DURECT Announces Appointment of Gail Maderis as Chair of the Board

March 21
Last Trade: 4.56 0.16 3.64

CUPERTINO, Calif., March 21, 2023 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today that Gail Maderis has assumed the role of Chair of the Board of DURECT effective March 17, 2023.  Ms. Maderis succeeds David Hoffmann as Chair of the Board. Mr. Hoffman has decided not to stand for re-election and will retire from the board on June 21, 2023 when his current term as a board member expires.    "We thank Dave...Read more


Bruno Rossi joins Olink as Chief Commercial Officer

March 21
Last Trade: 22.55 -0.25 -1.10

UPPSALA, Sweden, March 21, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced the appointment of life sciences industry veteran Bruno Rossi to the role of Chief Commercial Officer (CCO), effective immediately. Mr. Rossi will lead the Company’s global commercial organization including Sales, Marketing and Sales Operations. He will report to Carl Raimond, President of Olink. “I am delighted to welcome...Read more


Decibel Therapeutics Appoints Matthew Kapusta to its Board of Directors

March 21
Last Trade: 2.60 -0.05 -1.78

BOSTON, March 21, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced the appointment of Matthew Kapusta to its Board of Directors. “We are pleased to welcome Matt to the Decibel Board. He is an accomplished life sciences executive who has played a key role in...Read more


Nymox Pharmaceutical Announces Appointment of Christopher R. Riley as Chief Financial Officer

March 21
Last Trade: 0.40

IRVINE, Calif., March 21, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to announce the appointment of Christopher R. Riley as Chief Financial Officer (CFO) of Nymox.  Mr. Riley is a globally experienced executive and entrepreneur with many notable successes and has held major positions in large well known corporations.  He was CFO for...Read more


Beam Therapeutics Appoints Gopi Shanker, Ph.D., as Chief Scientific Officer

March 21
Last Trade: 30.63 0.23 0.76

CAMBRIDGE, Mass., March 21, 2023 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that Gopi Shanker, Ph.D., has been appointed as chief scientific officer (CSO). Dr. Shanker is a scientific leader with more than 20 years of drug development experience as well as experience with novel genetic medicine modalities. Dr. Shanker will...Read more


Minerva Surgical Announces the Appointment of Kaile Zagger as Chief Commercial Officer

March 21
Last Trade: 0.21 0.0001 0.05

SANTA CLARA, Calif., March 21, 2023 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical), a women's health company focused on solutions to meet the distinct uterine healthcare needs of women, announced today the appointment of Kaile Zagger as its new Chief Commercial Officer. Ms. Zagger’s leadership will help guide the strategic growth of the company and advance its position as a leader in women’s healthcare...Read more


Akoya Biosciences Announces Leadership Transition

March 20
Last Trade: 7.86 -0.02 -0.25

Joe Driscoll to Retire After More than Four Successful Years as Chief Financial Officer Johnny Ek Appointed as new Chief Financial Officer MARLBOROUGH, Mass., March 20, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that Chief Financial Officer Joe Driscoll is retiring from his position, effective March 20, 2023. Johnny Ek has been appointed as the company’s...Read more


Gamida Cell Announces Changes to Board of Directors

March 20
Last Trade: 1.09 -0.26 -19.35

BOSTON / Mar 20, 2023 / Business Wire / Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced the resignation of Chairman Robert I. Blum. The Board of Directors has elected Shawn Cline Tomasello Chairwoman, effective immediately. “On behalf of my fellow board members and Gamida Cell’s employees, I want to thank Robert for his dedicated service to this company,” said Abbey...Read more


InspireMD Announces Promotion of Andrea Tommasoli to Chief Operating Officer

March 20
Last Trade: 1.09 -0.005 -0.46

TEL AVIV, Israel, March 20, 2023 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that it has promoted Andrea Tommasoli to Chief Operating Officer. Mr. Tommasoli formerly served as the Company’s Senior Vice President of Global Sales & Marketing since joining InspireMD in November 2020. “Andrea has been instrumental in...Read more


FONAR Board of Directors Appoints Independent Director

Melville, New York--(Newsfile Corp. - March 20, 2023) - FONAR Corporation (NASDAQ: FONR), The Inventor of MR Scanning, today announced that its board of directors appointed Jessica Maher as a replacement independent director to a vacancy on the Company's board of directors and audit committee. Timothy Damadian, chairman, president and CEO of FONAR, said, "FONAR's primary source of income and growth is attributable to its diagnostic...Read more


Modivcare Announces Appointment of Anne Bailey as President of its Home Division

March 20
Last Trade: 83.30 1.14 1.39

DENVER / Mar 20, 2023 / Business Wire / Modivcare Inc. (the “Company” or “Modivcare”) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced the appointment of Anne Bailey as President of its Home division. “I am confident Anne is the right leader for our Home division as we expand our geographic footprint,...Read more


PaxMedica Holds Meeting of Scientific Advisory Board

March 20
Last Trade: 2.10 0.22 11.59

Board Includes Several Key Opinion Leaders on Autism Spectrum Disorder in U.S. TARRYTOWN, NY, March 20, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – PaxMedica, Inc. (Nasdaq: PXMD), a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic drug therapies (“APT”) for the treatment of disorders with intractable neurologic symptoms, today announced that it held a Scientific Advisory Board meeting on...Read more


Lantheus Announces Two Key Executive Promotions

March 17
Last Trade: 81.13 -0.30 -0.37

BEDFORD, Mass., March 17, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease, today announced that Paul Blanchfield has been promoted to President and Dan Niedzwiecki has been promoted to Chief Administrative Officer. “Paul was...Read more


Zomedica Appoints New Chief Financial Officer

March 17
Last Trade: 0.21 -0.0029 -1.38

ANN ARBOR, MI / ACCESSWIRE / March 17, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, announced that it has appointed Peter L. Donato as its Chief Financial Officer, effective March 16, 2023. Mr. Donato brings over 30 years of public and private company experience in a wide range of finance and...Read more


Vanda Pharmaceuticals Appoints Dr. Tage Honoré to Board of Directors

March 17
Last Trade: 6.76 0.01 0.15

WASHINGTON, March 17, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the appointment of Tage Honoré, Ph.D., D.Sc. to its Board of Directors effective March 15, 2023. Following Dr. Honoré's appointment, Vanda's Board of Directors is now comprised of six directors, five of whom are independent. "Tage is a highly accomplished industry leader and respected scientist with deep experience across a...Read more


AVITA Medical Appoints New Non-Executive Member to the Board of Directors

March 16
Last Trade: 13.51 0.67 5.22

VALENCIA, Calif. and MELBOURNE, Australia, March 16, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, announced today the appointment of Cary Vance to its Board of Directors, effective April 1, 2023. Mr. Vance has over 25 years of extensive leadership...Read more


Clene Appoints Neurology Expert Benjamin Greenberg to Executive Team

March 16
Last Trade: 1.15 -0.0001 -0.01

SALT LAKE CITY, March 16, 2023 (GLOBE NEWSWIRE) -- Clene, Inc. (Nasdaq: CLNN) along with its subsidiaries “Clene” and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative disease, today announced the appointment of Benjamin Greenberg, M.D., M.H.S. as Head of Medical.    An internationally recognized expert in treating...Read more


Sage Therapeutics Appoints Jessica Federer to Board of Directors

March 16
Last Trade: 43.37 0.46 1.07

CAMBRIDGE, Mass. / Mar 16, 2023 / Business Wire / Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, today announced the appointment of Jessica Federer to the company’s Board of Directors. “We are thrilled to have Jessica join our Board of Directors. Jessica is a champion for patients and has a track record of innovation in data and digital transformation which...Read more


Microbot Medical Launches Presence in the United Kingdom as Highly Accomplished Consultant Interventional Radiologist Professor Mark W. Little Joins its Scientific Advisory Board as Efforts to Commercialize the LIBERTY® Robotic System Continue to...

HINGHAM, Mass., March 16, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), which is rapidly scaling up its internal capabilities with globally renowned members joining its Scientific Advisory Board (SAB), today announced that Professor Mark W. Little, BSc(hons), MSc (Distinction), MBBS (Distinction), DipIPEM, FHEA, FRCR, FCIRSE, has joined the SAB, becoming the first member from the United Kingdom. Professor Little is...Read more


Invitae Appoints Dr. W. Michael Korn as Chief Medical Officer for Oncology

March 16
Last Trade: 1.28 -0.01 -0.78

Expert in the field of gastrointestinal cancer and precision oncology to lead Invitae's medical oncology team with a particular focus on somatic testing development  Invitae reports inducement grant under NYSE Rule 303A.08  SAN FRANCISCO, March 16, 2023 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced the appointment of W. Michael Korn, M.D., as its chief medical officer for...Read more


MediWound Announces the Appointment of Hani Luxenburg as Chief Financial Officer

March 16
Last Trade: 11.92 -0.20 -1.65

YAVNE, Israel, March 16, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully integrated biopharmaceutical company specializing in next-generation biotherapeutic solutions for tissue repair and regeneration, is pleased to announce the appointment of Ms. Hani Luxenburg as its new Chief Financial Officer, effective May 14, 2023. Ms. Luxenburg will replace Mr. Boaz Gur-Lavie, who has served as MediWound’s Chief Financial Officer...Read more


Standard BioTools Announces Appointment of Fenel Eloi to Board of Directors

March 15
Last Trade: 2.06 -0.02 -0.72

SOUTH SAN FRANCISCO, Calif., March 15, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today announced the appointment of Fenel Eloi to its Board of Directors (“Board”). Eloi will also serve on the Board’s Audit Committee. Eloi was most recently the Chief Financial Officer and then Chief Operating Officer of Cell Signaling...Read more


Oscar Health Appoints Dr. Sean Martin, MD as New Chief Medical Officer

March 15
Last Trade: 3.48 0.12 3.42

NEW YORK / Mar 15, 2023 / Business Wire / Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built on a full stack technology platform, today announced that Dr. Sean Martin, MD has been appointed to serve as the company’s new Chief Medical Officer, effective immediately. Dr. Martin joined Oscar in 2016 and during his tenure has provided clinical leadership across a number of core clinical functions, including...Read more


Clearmind Medicine Appoints Professor Henry R. Kranzler, M.D., to Scientific Advisory Board

March 14
Last Trade: 2.29 -0.20 -8.01

Professor Kranzler is the Benjamin Rush Professor of Psychiatry and Director of the Center for Studies of Addiction at the University of Pennsylvania’s Perelman School of Medicine Tel Aviv, Israel / Vancouver, Canada, March 14, 2023 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (CSE: CMND), (FSE: CWY) (“Clearmind” or the "company"), a biotech company focused on discovery and development of novel psychedelic-derived...Read more


Geisinger and Acadia Healthcare Appoint Kelly Ankenbrand as CEO of Geisinger Behavioral Health Center Northeast

March 14
Last Trade: 70.73 0.57 0.81

MOOSIC, Pa. / Mar 14, 2023 / Business Wire / Geisinger and Acadia Healthcare have named Kelly Ankenbrand, M.B.A., as chief executive officer for Geisinger Behavioral Health Center Northeast, a new 96-bed inpatient behavioral health hospital being built through a joint venture partnership between Geisinger and Acadia in Moosic. Ms. Ankenbrand succeeds Jenna Pacini. Ms. Pacini was named CEO in August 2022 with Ms. Ankenbrand as...Read more


Tactile Systems Technology Medical Appoints Elaine Birkemeyer as Chief Financial Officer

March 14
Last Trade: 16.65 0.09 0.54

MINNEAPOLIS, March 14, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Elaine Birkemeyer to the position of Chief Financial Officer, effective March 20, 2023. Ms. Birkemeyer will succeed Brent Moen, who is retiring. “Elaine is a dynamic and purpose-driven...Read more


Accelerate Diagnostics announces departure of CFO Steve Reichling and appointment of David Patience as replacement

March 14
Last Trade: 0.51 0.02 3.72

TUCSON, Ariz., March 14, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX) a leading provider of innovative rapid diagnostic solutions, announced today that Steve Reichling will be stepping down as Chief Financial Officer (CFO), effective March 31, 2023. David Patience, who previously served as Senior Director - Head of Business Development and Strategic Finance has been named as the company's new CFO, effective April 1,...Read more


Ultragenyx Pharmaceutical Appoints Dr. Eric Crombez Chief Medical Officer and Executive Vice President

March 14
Last Trade: 37.98 0.30 0.80

NOVATO, Calif., March 14, 2023 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) announced that Eric Crombez, M.D., has been promoted to chief medical officer and executive vice president effective May 1, 2023, succeeding Camille Bedrosian, M.D., who will remain with the company in a full-time strategic advisory role. Dr. Crombez currently serves as Ultragenyx’s chief medical officer for gene therapy and inborn errors of...Read more


Amedisys Board Appoints Richard Ashworth as New President and Chief Executive Officer

March 13
Last Trade: 71.57 0.57 0.80

BATON ROUGE, La., March 13, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), the leading provider of quality home health, hospice, and high-acuity care services, today announced that its Board of Directors has named Richard Ashworth as President, Chief Executive Officer, and member of the Board of Directors. Ashworth will assume the role on April 10, 2023, from Chief Executive Officer Paul Kusserow. Kusserow will remain Chairman of...Read more


CRISPR Therapeutics Announces Transition of Chief Financial Officer

March 13
Last Trade: 44.89 1.46 3.36

ZUG, Switzerland and BOSTON, March 13, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, announces the hiring and appointment of Raju Prasad, Ph.D., as Chief Financial Officer, effective March 14, 2023. He joins CRISPR Therapeutics from William Blair & Company, where he served as a Partner and Senior Equity Research...Read more


iCAD Announces Leadership Transition

March 13
Last Trade: 1.31 0.03 2.34

Stacey Stevens Resigns as President and CEO and as a Member of the Board Dana Brown Named President and CEO, remains Chairman of the Board NASHUA, N.H., March 13, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the Board of Directors has accepted the resignation, for personal reasons, of Stacey Stevens as...Read more


HOOKIPA Pharma Appoints Terry Coelho to its Board of Directors

March 13
Last Trade: 0.79 0.03 3.81

NEW YORK and VIENNA, March 13, 2023 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, announced today that Terry Coelho will join its Board of Directors, Audit Committee and Compensation Committee, effective April 3, 2023. “Terry is an immensely valuable addition to our Board given her experience in business strategy,...Read more


Revelation Biosciences Appoints Dr. Julia Bohannon and Dr. Antonio Hernandez to Scientific Advisory Board

March 13
Last Trade: 1.44 -0.09 -5.88

SAN DIEGO / Mar 13, 2023 / Business Wire / Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on the development of immunologic-based therapies for the prevention and treatment of disease, today announced it has appointed Julia Bohannon, Ph.D. and Antonio Hernandez, M.D. to its scientific advisory board. Dr. Hernandez and Dr. Bohannon are inventors of the phosphorylated...Read more


The Joint Thanks Retiring Board Member James H. Amos, Jr.

March 13
Last Trade: 16.85 0.45 2.75

SCOTTSDALE, Ariz., March 13, 2023 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic clinics, announced James H. Amos, Jr. has notified the company that he will complete his term on May 25, 2023 and not stand for reelection at the company’s 2023 Annual Meeting of Stockholders scheduled for that day. The board membership will be reduced to six until a replacement is appointed or...Read more


ObsEva Announces Update Towards its Strategic Reorganization to Consolidate Operations in Switzerland

March 13
Last Trade: 0.10

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – March 13, 2023 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s health, today announced that Ernest Loumaye, MD, PhD, co-founder and member of the Board of Directors has been appointed as Interim Chairman following the resignation of Annette Clancy. It is expected that...Read more


Microbot Medical Increases Presence in the EU with the Addition of Greece-based Key Opinion Leader Stavros Spiliopoulos, MD, PhD, EBIR-ES, FCIRSE, to its Scientific Advisory Board

HINGHAM, Mass., March 13, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), which continues to experience a rising interest in the LIBERTY ® Robotic System, the first single-use endovascular robotic system, today announced that Stavros Spiliopoulos, MD, PhD, EBIR-ES, FCIRSE, a key opinion leader (KOL) from Greece, has joined the Company’s Scientific Advisory Board (SAB). The addition of Dr. Spiliopoulos, an Associate...Read more


NuGen Medical Devices Announces Return of Veronique Laberge as Chief Financial Officer and Corporate Secretary

March 10
Last Trade: 0.22 0.005 2.33

Toronto, Ontario--(Newsfile Corp. - March 10, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to announce that the Board of Directors has re-appointed Ms. Veronique Laberge as Chief Financial Officer and Corporate Secretary of the Company. "I am excited to return into the CFO role at NuGen and work with the new management team to help the company continue executing its strategic plan, accelerate...Read more


American Shared Hospital Services Realigns Management Team

March 10
Last Trade: 2.85 -0.02 -0.70

Ray Stachowiak Becomes Executive Chairman, Peter Gaccione Appointed CEO Craig Tagawa Remains President, Search Underway for CFO AMS Books First Order of 2023 SAN FRANCISCO, CA, March 10, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and...Read more


LAVA Therapeutics Announces Appointment of Christy J. Oliger to its Board of Directors

March 9
Last Trade: 1.60 0.01 0.63

UTRECHT, The Netherlands and PHILADELPHIA, March 09, 2023 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (Nasdaq: LVTX), a clinical-stage immuno-oncology company focused on developing its proprietary Gammabody™ platform of bispecific gamma-delta T cell engagers, today announced the appointment of Christy J. Oliger to its board of directors effective March 9, 2023. Ms. Oliger brings extensive commercial, portfolio management, and senior...Read more


Anavex Life Sciences Appoints Former FDA Lead Neurology Statistician as Vice President Head of Biostatistics

March 9
Last Trade: 8.70 -0.02 -0.23

NEW YORK, March 09, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) diseases, today announced the appointment of Kun Jin, Ph.D., as...Read more


Homology Medicines Announces Promotion of Julie Jordan, M.D., to Chief Medical Officer

March 9
Last Trade: 0.88 -0.03 -3.33

BEDFORD, Mass., March 09, 2023 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that Julie Jordan, M.D., has been promoted to Chief Medical Officer. Previously, Dr. Jordan held the role of Senior Vice President, Head of Clinical Development and Operations, at Homology, and she has been instrumental in advancing Homology’s gene editing and gene therapy clinical programs. Under her...Read more


Centogene Appoints Ian Rentsch as Chief Commercial Officer and General Manager - Pharma

March 9
Last Trade: 0.76 -0.02 -2.81

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, March 09, 2023 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced the appointment of Ian Rentsch as Chief Commercial Officer and General Manager - Pharma, who will join the Company on March 15, 2023. Mr. Rentsch is a globally experienced industry leader with over 25 years of...Read more


Pliant Therapeutics Announces Appointments of Darren Cline and Thomas McCourt to Board of Directors

March 8
Last Trade: 25.93 0.33 1.29

SOUTH SAN FRANCISCO, Calif., March 08, 2023 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced the appointments of Darren Cline and Thomas McCourt to its Board of Directors. "I am pleased to welcome Darren and Thomas whose extensive commercial and operational expertise will be crucial...Read more


HeartBeam Announces Senior Leadership Change

March 8
Last Trade: 2.47 -0.05 -1.79

SANTA CLARA, Calif. / Mar 08, 2023 / Business Wire / HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform for heart attack detection anytime, anywhere, has announced a senior leadership change ahead of key milestones in 2023 including FDA clearance for the HeartBeam AIMI™ system and FDA submission of the HeartBeam AIMIGo™ 3D vector ECG first generation...Read more


Cardio Diagnostics Welcomes Dr. Damon Broyles, MD, as Strategic Advisor for Precision Cardiovascular Medicine Strategy

March 8
Last Trade: 4.40 0.04 0.92

CHICAGO / Mar 08, 2023 / Business Wire / Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, today announced Dr. Damon Broyles, MD, the VP of Clinical Innovation at Mercy Technology Services (MTS), the technical support arm of Mercy Healthcare, has joined Cardio Diagnostics as a strategic advisor. Strategic advisors at Cardio Diagnostics are pivotal in providing...Read more


James D. Swift, M.D., Elected to Pediatrix Medical Board of Directors

March 8
Last Trade: 14.33 0.20 1.42

FORT LAUDERDALE, Fla. / Mar 08, 2023 / Business Wire / Pediatrix Medical Group, Inc. (NYSE: MD) today announced that its board of directors has elected James D. Swift, M.D., the Company’s chief executive officer, as a director effective March 8, 2023. This appointment fills a seat previously held by Roger J. Medel, M.D. “Jim’s election follows his recent appointment as chief executive officer,” said Mark S. Ordan, executive chair of...Read more


Caroline Dorsa to Succeed Stelios Papadopoulos as Chair of Biogen Board of Directors

March 8
Last Trade: 270.73 0.70 0.26

CAMBRIDGE, Mass., March 08, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (NASDAQ: BIIB) today announced that the Board of Directors has elected Caroline Dorsa as Chair of the Board of Directors, effective immediately following the Company’s 2023 Annual Meeting of Stockholders (the “Annual Meeting”), scheduled to take place on June 14, 2023. Ms. Dorsa will succeed Stelios Papadopoulos, Ph.D., who announced he would not stand for reelection to the...Read more


Accelerate Diagnostics announces appointment of Hany Massarany to Chairman of Board of Directors

March 8
Last Trade: 0.51 0.02 3.72

TUCSON, Ariz., March 8, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) a disruptor in bloodstream infection identification and susceptibility testing today announced the appointment of Hany Massarany to chairman of the company's board of directors effective February 22, 2023. Jack Phillips, Chief Executive Officer of Accelerate Diagnostics, stated, "I am excited for Hany to step into this very important role as...Read more


2seventy bio Announces Appointment of Wei Lin, M.D. to Board of Directors

March 8
Last Trade: 9.59 0.35 3.79

CAMBRIDGE, Mass. / Mar 08, 2023 / Business Wire / 2seventy bio, Inc. (Nasdaq: TSVT) today announced the appointment of Wei Lin, M.D. to the company’s Board of Directors, effective immediately. “We are thrilled to welcome Dr. Wei Lin to 2seventy’s Board during an exciting time in our Company’s growth,” said Nick Leschly, chief kairos officer. “Wei’s leadership and deep expertise in clinical development strategy for cancer immunotherapy...Read more


Aditxt Names Media Industry Veteran Maureen Connolly as Chief Content and Engagement Officer

March 8
Last Trade: 0.89 0.04 4.18

RICHMOND, Va. / Mar 08, 2023 / Business Wire / Aditxt, Inc., (NASDAQ: ADTX) (“Aditxt” or the “Company”), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, is pleased to announce Maureen Connolly has joined Aditxt as Chief Content and Engagement Officer. Connolly is an award-winning content strategist and audience builder with 25+ years of experience in the health,...Read more


Oragenics Appoints Janet Huffman as Chief Financial Officer Strengthening Executive Leadership Team

March 8
Last Trade: 2.75 0.02 0.73

TAMPA, Fla. / Mar 08, 2023 / Business Wire / Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”), a biotechnology company dedicated to fighting infectious diseases including COVID-19, announces the appointment of Janet Huffman as Chief Financial Officer, effective March 7, 2023. Ms. Huffman is a seasoned financial executive with more than a dozen years of leadership experience at publicly traded and private healthcare...Read more


Alnylam Pharmaceuticals Announces Appointment of Peter Kellogg to Board of Directors

March 8
Last Trade: 189.70 -0.28 -0.15

CAMBRIDGE, Mass. / Mar 08, 2023 / Business Wire / Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) the leading RNAi therapeutics company, announced today the appointment of Peter Kellogg to its Board of Directors. Mr. Kellogg is an accomplished industry executive with extensive global financial and strategic management experience. “Mr. Kellogg joins our Board at a pivotal moment for Alnylam as we continue on the path to achieving our P5x25...Read more


Editas Medicine Strengthens Executive Leadership Team with Appointment of Linea Aspesi as Chief People Officer

March 8
Last Trade: 7.58 0.12 1.61

CAMBRIDGE, Mass., March 08, 2023 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced the appointment of Linea Aspesi as the Company’s Executive Vice President and Chief People Officer. Ms. Aspesi will lead Editas’ human resources department and the Company’s people strategy in support of its mission and goals. “Our people and our culture are critical ingredients for the...Read more


MaxCyte Establishes New Scientific Advisory Board Comprised of Globally Recognized Experts in Cell Engineering Enabling Technology

March 8
Last Trade: 4.08 -0.01 -0.24

ROCKVILLE, Md., March 08, 2023 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research, today announced the formation of its new Scientific Advisory Board (SAB) that will reflect the cutting edge of...Read more


Anebulo Pharmaceuticals Expands its Integrated and Outsourced Solutions

Additional operational efficiencies and opportunities expected with the engagement of Potrero Hill Advisors Sandra Gardiner succeeds Rex Merchant as acting chief financial officer AUSTIN, Texas, March 8, 2023 /PRNewswire/ -- Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB) (the "Company" or "Anebulo"), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication ("ACI")...Read more


ZyVersa Therapeutics Adds Dr. Richard J. Glassock to Renal Scientific Advisory Board to Support Clinical Advancement of Renal Cholesterol Efflux Mediator™ VAR 200

March 7
Last Trade: 2.16 -0.02 -0.92

Cholesterol Efflux Mediator VAR 200 is a phase 2a-ready drug in development to ameliorate renal lipid accumulation that damages the kidneys’ filtration system, leading to progression of kidney disease WESTON, Fla., March 07, 2023 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of patients with renal and...Read more


Covant Therapeutics Announces the Formation of its Scientific Advisory Board to Support Platform and Pipeline Advancement

March 7
Last Trade: 7.06 0.14 2.02

BOSTON, March 07, 2023 (GLOBE NEWSWIRE) -- Covant Therapeutics, an innovative covalent drug discovery company incubated by Roivant Sciences (Nasdaq: ROIV), today announced the formation of its Scientific Advisory Board (SAB). Covant uses its unprecedented high-throughput chemoproteomics platform to discover novel small molecule therapeutics against hard-to-drug immunology and oncology targets. “This is a very exciting time for Covant as...Read more


Gemina Labs Appoints Diagnostic Strategist Martha Najib to the Board

March 7
Last Trade: 0.52 -0.08 -13.33

VANCOUVER, BC / ACCESSWIRE / March 7, 2023 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is delighted to announce that it has appointed Martha Najib as an independent director of the Company. Ms. Najib brings an exceptionally strong and accomplished record in the diagnostics industry to Gemina. With more than 20 years of award-winning US and global healthcare experience, she is highly recognized and respected...Read more


Aclarion Announces Alpesh Patel MD MBA as a Key Opinion Leader Physician Advisor

Marks the eighth advisor to growing KOL program to build strong body of clinical evidence and support US commercialization Aclarion to participate in upcoming SPINEWEEK 2023 Broomfield, CO, March 07, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help...Read more


Assertio Appoints Dr. Howard Franklin as Senior Vice President, Medical

March 6
Last Trade: 5.96 0.09 1.54

LAKE FOREST, Ill., March 06, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced the appointment of Howard J. Franklin, MD, as Senior Vice President, Medical. “We see significant opportunities to expand the addressable market and label indications for key assets in our portfolio, in particular...Read more


Krystal Biotech Appoints Catherine Mazzacco to Board of Directors

March 6
Last Trade: 79.04 1.15 1.48

PITTSBURGH, March 06, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) a biotechnology company focused on developing and commercializing genetic medicines for patients with rare diseases, today announced the appointment of Catherine Mazzacco to its Board of Directors. “I am pleased to welcome Catherine to our Board of Directors at this crucial next stage of Krystal’s evolution,” said Krish S. Krishnan,...Read more


DiaMedica Therapeutics Announces the Appointment of Biopharma Veteran Tanya Lewis to Its Board of Directors

MINNEAPOLIS / Mar 06, 2023 / Business Wire / DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, announced today the appointment of Tanya Lewis to its board of directors effective March 1, 2023. Ms. Lewis, a recognized leader in the biopharma industry, brings over 25 years of experience in drug development, having played...Read more


Ocugen Appoints Quan A. Vu to Chief Financial Officer & Chief Business Officer

March 6
Last Trade: 0.91 -0.02 -1.96

MALVERN, Pa., March 06, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today announced the appointment of Quan A. Vu to Chief Financial Officer & Chief Business Officer. “Quan has quickly become a tremendous asset for Ocugen and his comprehensive healthcare and...Read more


Edgewise Therapeutics Appoints Industry Veteran Jonathan C. Fox, M.D., Ph.D., FACC to its Board of Directors

March 6
Last Trade: 6.78 -0.09 -1.31

BOULDER, Colo. / Mar 06, 2023 / Business Wire / Edgewise Therapeutics, Inc., (NASDAQ: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, targeted, small molecule therapies for individuals with devastating muscle disorders, announced today the appointment of Jonathan C. Fox, M.D., Ph.D., FACC, to its Board of Directors. Dr. Fox brings considerable expertise in clinical development and regulatory...Read more


MediWound Expands its Global Leadership Team to Help Drive Company’s Future Growth

March 6
Last Trade: 11.92 -0.20 -1.65

Appoints Barry Wolfenson, as Executive Vice President of Strategy and Corporate Development Appoints Alicia Torrenova, as Vice President of European Operations Both bring extensive leadership experience and expertise in wound care and regenerative medicine YAVNE, Israel, March 06, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ: MDWD) (the “Company”), a fully integrated biopharmaceutical company focused on next-generation...Read more


Harrow Announces Appointment of Mark Mannebach, Ph.D., R.Ph. as Head of Regulatory Affairs and Pharmacovigilance

March 6
Last Trade: 19.97 1.55 8.41

NASHVILLE, Tenn. / Mar 06, 2023 / Business Wire / Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced the appointment of Mark Mannebach, Ph.D., R.Ph. as Head of Regulatory Affairs and Pharmacovigilance, responsible for overseeing and managing all regulatory related submissions and strategy related to the Company’s portfolio of new and existing products. Dr. Mannebach’s successful 30-year career in the...Read more


Catalent Appoints Sridhar Krishnan to Lead New Global Operational Excellence Strategy, “The Catalent Way”

March 6
Last Trade: 68.49 4.22 6.57

SOMERSET, N.J. / Mar 06, 2023 / Business Wire / Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced the appointment of Sridhar Krishnan, to the newly created position of Vice President, The Catalent Way, where he will lead the company’s operational excellence strategy and spearhead a transformation based on Lean principles, designed to drive sustainable...Read more


Avanos Medical Appoints Dr. Lisa Egbuonu-Davis to Board of Directors

March 6
Last Trade: 29.19 0.62 2.17

ALPHARETTA, Ga., March 6, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Dr. Lisa Egbuonu-Davis, currently vice president, medical innovations, for DH Diagnostics, LLC, an affiliate of Danaher Corporation, has been appointed as a new independent member of the Avanos board of directors and will serve as a member of the compliance and governance committees. "We are pleased and excited to welcome Lisa...Read more


Axogen Appoints Marc Began as Executive Vice President and General Counsel

March 6
Last Trade: 9.17 0.11 1.21

ALACHUA, Fla. and TAMPA, Fla., March 06, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the appointment of Marc Began as Executive Vice President. Additionally, effective March 20, 2023, Mr. Began will be Axogen’s General Counsel, replacing Brad Ottinger, General Counsel and Chief Compliance Officer. As a member...Read more


Asep Medical Appoints General Wesley Clark (Ret.), David Johnson, J. Bernard Rice, Dr. Islam Mohamed and Thomas O'Shaughnessy to its Advisory Board and Dr. Rob Stenstrom, as Medical Director

March 6
Last Trade: 0.27

VANCOUVER, BC, March 6, 2023 /CNW/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is delighted to announce the appointments of five new members to its advisory board, all of which take effect immediately and the appointment of Dr. Rob Stenstrom, as Medical Director, effective February 24, 2023. The Company also announces the grant of stock options and restricted share...Read more


Corbus Pharmaceuticals Expands Board of Directors with Appointment of Yong Ben, M.D., MBA

March 6
Last Trade: 6.72 -0.13 -1.90

NORWOOD, Mass., March 6, 2023 /PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a precision oncology company, today announced the appointment of Yong Ben, M.D., MBA, to the Company's Board of Directors. "Dr. Ben is a distinguished oncology researcher and pharma industry executive, with multiple drug approvals to his credit, and his appointment is a welcome addition to our Board," said...Read more


Sign Up To Get Daily Health Stock News

Please review our Disclaimer and Privacy Policy before subscribing.

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

COPYRIGHT ©2023 HEALTH STOCKS HUB